Literature DB >> 17611791

Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves' thyrotoxicosis in pregnancy.

F M Finucane1, J O'Connell, B T Kinsley.   

Abstract

BACKGROUND: Thionamide induced agranulocytosis is associated with the presence of anti-neutrophil cytoplasmic antibodies (ANCA) in some patients. This poses a particular challenge when it occurs during pregnancy. AIMS: To report a case of a 31-year-old woman with Graves' disease who presented at 11 weeks gestation with propylthiouracil induced agranulocytosis.
METHODS: After cessation of propylthiouracil the patient developed recurrent thyrotoxicosis, and underwent an elective subtotal thyroidectomy at 23 weeks gestation.
RESULTS: The patient required postoperative thyroxine replacement therapy. Subsequent pregnancy was uneventful and she delivered a healthy baby boy at 41 weeks gestation. As part of our routine work up for agranulocytosis we measured C-ANCA levels, which were significantly elevated.
CONCLUSION: This case highlights the association of propylthiouracil induced ANCA positivity and agranulocytosis. Second trimester subtotal thyroidectomy was safe and effective in treating this pregnant patient's thyrotoxicosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611791     DOI: 10.1007/s11845-007-0055-5

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  10 in total

Review 1.  Hyperthyroidism in pregnancy: diagnosis and treatment.

Authors:  U S Masiukiewicz; G N Burrow
Journal:  Thyroid       Date:  1999-07       Impact factor: 6.568

2.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 21-2002. A 21-year-old man with arthritis during treatment for hyperthyroidism.

Authors:  Simon M Helfgott; R Neal Smith
Journal:  N Engl J Med       Date:  2002-07-11       Impact factor: 91.245

Review 3.  Clinical review 80: Management of hyperthyroidism and hypothyroidism in the pregnant woman.

Authors:  E Roti; R Minelli; M Salvi
Journal:  J Clin Endocrinol Metab       Date:  1996-05       Impact factor: 5.958

Review 4.  Management of thyrotoxicosis in pregnancy.

Authors:  A Ghaneim; P Atkins
Journal:  Int J Clin Pract       Date:  1998 Jan-Feb       Impact factor: 2.503

Review 5.  The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology.

Authors:  D Glinoer
Journal:  Endocr Rev       Date:  1997-06       Impact factor: 19.871

6.  Management of a pregnant patient with Graves' disease complicated by thionamide-induced neutropenia in the first trimester.

Authors:  S Davison; T W Lennard; J Davison; P Kendall-Taylor; P Perros
Journal:  Clin Endocrinol (Oxf)       Date:  2001-04       Impact factor: 3.478

7.  Thyrotoxicosis complicating pregnancy.

Authors:  L E Davis; M J Lucas; G D Hankins; M L Roark; F G Cunningham
Journal:  Am J Obstet Gynecol       Date:  1989-01       Impact factor: 8.661

8.  Iodide goiter in the newborn.

Authors:  B Senior; H L Chernoff
Journal:  Pediatrics       Date:  1971-03       Impact factor: 7.124

9.  Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis.

Authors:  Junichi Tajiri; Shiro Noguchi
Journal:  Thyroid       Date:  2004-06       Impact factor: 6.568

10.  Rapid preoperative preparation in hyperthyroidism.

Authors:  A Baeza; J Aguayo; M Barria; G Pineda
Journal:  Clin Endocrinol (Oxf)       Date:  1991-11       Impact factor: 3.478

  10 in total
  4 in total

Review 1.  Side effects of anti-thyroid drugs and their impact on the choice of treatment for thyrotoxicosis in pregnancy.

Authors:  Peter N Taylor; Bijay Vaidya
Journal:  Eur Thyroid J       Date:  2012-09-24

2.  Patient knowledge of antithyroid drug-induced agranulocytosis.

Authors:  Jonah Robinson; Max Richardson; Janis Hickey; Andy James; Simon H Pearce; Steve G Ball; Richard Quinton; Margaret Morris; Margaret Miller; Petros Perros
Journal:  Eur Thyroid J       Date:  2014-10-15

3.  Antineutrophil cytoplasmic antibodies, autoimmune neutropenia, and vasculitis.

Authors:  Peter C Grayson; J Mark Sloan; John L Niles; Paul A Monach; Peter A Merkel
Journal:  Semin Arthritis Rheum       Date:  2011-04-19       Impact factor: 5.532

4.  Graves' Disease Thyrotoxicosis and Propylthiouracil Related Agranulocytosis Successfully Treated with Therapeutic Plasma Exchange and G-CSF Followed by Total Thyroidectomy.

Authors:  Anna Candoni; Federico De Marchi; Fabio Vescini; Sara Mauro; Cristina Rinaldi; Marco Piemonte; Nicholas Rabassi; Maria Vittoria Dubbini; Renato Fanin
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-10-16       Impact factor: 2.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.